lenacapavir

A once-yearly PrEP? Gilead's lenacapavir shows promise as company plots phase 3
Fierce Pharma
Tue, 03/11/25 - 07:10 pm
Gilead Sciences
lenacapavir
HUV
PrEP
FDA sets June date for Gilead's twice-yearly HIV PrEP
Pharmaphorum
Wed, 02/19/25 - 09:42 am
Gilead Sciences
FDA
PrEP
HIV
lenacapavir
Gilead, riding high from HIV sales boost, charts course for long-acting PrEP launch
Fierce Pharma
Wed, 02/12/25 - 11:16 am
Gilead Sciences
HIV
PrEP
lenacapavir
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial
Clinical Trials Arena
Sun, 12/1/24 - 11:46 am
Gilead Sciences
clinical trials
lenacapavir
HIV
PrEP
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Reuters
Wed, 10/2/24 - 09:55 pm
Gilead Sciences
generics
HIV
lenacapavir
Gilead’s twice-yearly shot cut HIV infections by 96% in trial
CNBC
Thu, 09/12/24 - 10:28 am
Gilead Sciences
HIV
lenacapavir
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters
Thu, 06/20/24 - 11:20 am
Gilead Sciences
lenacapavir
HIV
Truvada
Gilead Sciences reports positive data from HIV therapy trial
Clinical Trials Arena
Thu, 02/23/23 - 10:12 am
Gilead Sciences
lenacapavir
HIV
clinical trials
Gilead goes long-acting in HIV
EP Vantage
Fri, 12/23/22 - 10:35 am
Gilead Sciences
lenacapavir
HIV
FDA
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
FDA
Biogen
Eisai
Alzheimer's disease
Gilead Sciences
HIV
Mirati Therapeutics
lung cancer
lecanemab
lenacapavir
adagrasib
Gilead tries again with twice-yearly HIV drug lenacapavir
Pharmaforum
Tue, 06/28/22 - 05:52 pm
Gilead Sciences
HIV
FDA
lenacapavir
Gilead HIV prospect escapes FDA hold after glass compatibility glitch triggered regulatory setbacks
Fierce Pharma
Tue, 05/17/22 - 10:34 am
Gilead Sciences
drug manufacturing
FDA
HIV
lenacapavir
FDA rejects Gilead's closely watched HIV drug
BioPharma Dive
Tue, 03/1/22 - 10:05 pm
Gilead Sciences
HIV
FDA
lenacapavir
FDA slaps a hold on Gilead's injectable HIV treatment over concerns about potential glass contaminants
Endpoints
Wed, 12/22/21 - 11:01 am
Gilead Sciences
FDA
HIV
lenacapavir
clinical trials
clinical hold
Gilead cements its long-acting HIV ambitions
EP Vantage
Fri, 08/13/21 - 10:51 am
Gilead Sciences
HIV
lenacapavir
clinical trials
Gilead challenges ViiV in resistant HIV, filing twice-yearly therapy
Pharmaforum
Tue, 06/29/21 - 10:52 am
Gilead Sciences
HIV
ViiV Healthcare
FDA
lenacapavir
Rukobia
Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir
Pharmaforum
Thu, 11/19/20 - 10:18 am
Gilead Sciences
lenacapavir
HIV
New Data Shows Promise Involving Lenacapavir for the Treatment of HIV
BioSpace
Thu, 07/2/20 - 11:30 pm
Gilead Sciences
lenacapavir
HIV
Experimental HIV drug seems effective at a twice-a-year dose, study finds
Stat
Wed, 07/1/20 - 11:25 am
HIV
Gilead Sciences
lenacapavir
clinical trials